TrialChemotherapy2009
A phase II study of docetaxel and oxaliplatin for second-line treatment of urothelial carcinoma.
Sandy Srinivas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
TrialChemotherapy2009
Sandy Srinivas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.